These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37863443)

  • 1. Development of a tadalafil transdermal formulation and evaluation of its ability to in vitro transdermal permeate using Strat-M® membrane.
    Sohn JS; Choi JS
    Eur J Pharm Sci; 2024 Jan; 192():106615. PubMed ID: 37863443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and evaluation of niacinamide transdermal formulation by artificial membrane permeability.
    Sohn JS; Choi JS
    Saudi Pharm J; 2023 Jul; 31(7):1229-1236. PubMed ID: 37284416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strat-M® synthetic membrane: Permeability comparison to human cadaver skin.
    Haq A; Goodyear B; Ameen D; Joshi V; Michniak-Kohn B
    Int J Pharm; 2018 Aug; 547(1-2):432-437. PubMed ID: 29890259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal delivery of tadalafil using a novel formulation.
    Baek JS; Cho CW
    Drug Deliv; 2016 Jun; 23(5):1571-7. PubMed ID: 26289211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solubilization of tadalafil using a tartaric acid and chitosan-based multi-system.
    Sohn JS; Choi JS
    Int J Biol Macromol; 2021 Jan; 168():866-874. PubMed ID: 33249149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tadalafil solid dispersion formulations based on PVP/VA S-630: Improving oral bioavailability in rats.
    Choi JS; Lee SE; Jang WS; Byeon JC; Park JS
    Eur J Pharm Sci; 2017 Aug; 106():152-158. PubMed ID: 28579005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of in Vitro and in Vivo Transdermal Absorption of Solifenacin Succinate.
    Yoshida M; Uchida S; Kashiwagura Y; Tanaka S; Matsui R; Namiki N
    Chem Pharm Bull (Tokyo); 2019; 67(11):1225-1231. PubMed ID: 31685750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanovesicular carrier-mediated transdermal delivery of tadalafil: i-formulation and physicsochemical characterization.
    Mehanna MM; Motawaa AM; Samaha MW
    Drug Dev Ind Pharm; 2015 May; 41(5):714-21. PubMed ID: 24669976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of rivastigmine permeation from a transdermal system in the Franz cell using synthetic membranes and pig ear skin with in vivo-in vitro correlation.
    Simon A; Amaro MI; Healy AM; Cabral LM; de Sousa VP
    Int J Pharm; 2016 Oct; 512(1):234-241. PubMed ID: 27568498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of acidifier and solubilizer in tadalafil solid dispersion to enhance the in vitro dissolution and oral bioavailability in rats.
    Choi JS; Kwon SH; Lee SE; Jang WS; Byeon JC; Jeong HM; Park JS
    Int J Pharm; 2017 Jun; 526(1-2):77-87. PubMed ID: 28450170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
    Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
    J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
    Aboofazeli R; Zia H; Needham TE
    Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of PVP/VA S-630 based tadalafil solid dispersion to enhance the dissolution rate.
    Choi JS; Park JS
    Eur J Pharm Sci; 2017 Jan; 97():269-276. PubMed ID: 27919702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Relationship between Solubility and Transdermal Absorption of Tadalafil.
    Hamishehkar H; Khoshbakht M; Jouyban A; Ghanbarzadeh S
    Adv Pharm Bull; 2015 Sep; 5(3):411-7. PubMed ID: 26504764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal delivery of tadalafil. I. Effect of vehicles on skin permeation.
    El Maghraby GM; Alanazi FK; Alsarra IA
    Drug Dev Ind Pharm; 2009 Mar; 35(3):329-36. PubMed ID: 18821150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane properties for permeability testing: Skin versus synthetic membranes.
    Haq A; Dorrani M; Goodyear B; Joshi V; Michniak-Kohn B
    Int J Pharm; 2018 Mar; 539(1-2):58-64. PubMed ID: 29366943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Versatility of hydrogel-forming microneedles in in vitro transdermal delivery of tuberculosis drugs.
    Anjani QK; Permana AD; Cárcamo-Martínez Á; Domínguez-Robles J; Tekko IA; Larrañeta E; Vora LK; Ramadon D; Donnelly RF
    Eur J Pharm Biopharm; 2021 Jan; 158():294-312. PubMed ID: 33309844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fatty acids on the transdermal delivery of donepezil: in vitro and in vivo evaluation.
    Choi J; Choi MK; Chong S; Chung SJ; Shim CK; Kim DD
    Int J Pharm; 2012 Jan; 422(1-2):83-90. PubMed ID: 22037444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the Efficacy of Transdermal Penetration Enhancers Through the Use of Human Skin and a Skin Mimic Artificial Membrane.
    Balázs B; Vizserálek G; Berkó S; Budai-Szűcs M; Kelemen A; Sinkó B; Takács-Novák K; Szabó-Révész P; Csányi E
    J Pharm Sci; 2016 Mar; 105(3):1134-40. PubMed ID: 26886318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of gellan gum containing formulations for transdermal drug delivery: Component evaluation and controlled drug release using temperature responsive nanogels.
    Carmona-Moran CA; Zavgorodnya O; Penman AD; Kharlampieva E; Bridges SL; Hergenrother RW; Singh JA; Wick TM
    Int J Pharm; 2016 Jul; 509(1-2):465-476. PubMed ID: 27260133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.